Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

MAR 19, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Lowers PT on Synergy Pharmaceuticals; Stating Dilution

Cantor Fitzgerald analyst Adeyemi Ogunkoya published a report on Synergy Parmaceuticals (NASDAQ: SGYP) that lowered the price target from $13 to $12 and maintained a Buy rating stating larger-than-expected share count dilution. In the report Cantor Fitzgerald said, "Synergy reported an operational loss of ($12.0M) and loss per share of ($0.18) rel

Tags: UPDATE: Cantor Fitzgerald Lowers PT on Synergy Pharmaceuticals; Stating Dilution,  Cantor Fitzgerald Latest News